Introducción metodología de elaboración de la guíA



Descargar 0.88 Mb.
Página13/13
Fecha de conversión01.07.2017
Tamaño0.88 Mb.
1   ...   5   6   7   8   9   10   11   12   13
The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.

  • Duley L, Henderson-Smart DJ, Knight M, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.

  • Duley L, Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.

  • Duley L, Henderson-Smart D. Magnesium sulphate versus diazepam for eclampsia (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.

  • Recommendations of the Epilepsy Foundation of America´s Working Group on Status Epilepticus. Treatment of Convulsive Status Epilepticus. Jama 1993; 270(7): 854-859.

  • DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, Garnett L, Fortner CA, Ko D. A prospective, population-based Epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996; 46(4): 1029-35.

  • Delgado-Escueta AV, Fong Ch. Status epilepticus: recent trends and prospects. Neurología 1997; 12(6): 62-73.

  • Treiman DM., Meyers PD., Walton NY., Collins JF. y col. A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 1998; 339: 792-798.

  • Appleton R, Martland T, Phillips B. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.

  • Yu KT, Mills S, Thompson N, Cunanan C. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Epilepsia 2003; 44(5): 724-6.

  • Bleck TP. Management Approaches to Prolonged Seizures and Status Epilepticus. Epilepsia 1999; 40(1): S59-S63.

  • Sirven JI. Waterhouse E. Management of status epilepticus. American Family Physician. 2003; 68(3): 469- 476.

  • Ulvi H, Yoldas T, Mungen B, Yigiter R. Continuous infusion of midazolam in the treatment of refractory generalized convulsive status epilepticus. Neurol Sci.2002; 23(4): 177-82.

  • Drislane FW. Presentation, Evaluation, and Treatment of Nonconvulsive Status Epilepticus. Epilepsia 2000; 1(5): 301-314.

  • Walker MC. Diagnosis and treatment of nonconvulsive status epilepticus. CNS Drugs 2001; 15(2): 931-9.

  • Krumholz A. Epidemiology and evidence for morbidity of nonconvulsive status epilepticus. J Clin Neurophysiol. 1999; 16(4): 314-22.Ruegg SJ, Dichter MA. Diagnosis and treatment of nonconvulsive status epilepticus in an intensive care unit setting. Curr Treat Options Neurol 2003; 5(2): 93-110.




    1. Serrano-Castro PJ, Sánchez-Álvarez JC. Controversias en torno a los nuevos fármacos antiepilépticos. Rev Neurol 2001; 31: 165-71.




    1. Rufo-Campos M. Epilepsias parciales en la infancia. Rev Neurol 2001; 32: 962-9.




    1. Sánchez-Alvarez JC, Serrano-Castro P, Cañadillas-Hidalgo F. Epilepsia refractaria del adulto. Rev Neurol 2002; 35: 931-53.




    1. Benbadis SR, Tatum WO, Vale FL. When drugs don´t work. An algorithmic approach to medically intractable epilepsy. Neurology 2000; 55: 1780-4.




    1. Berg AT, Shinnar S, Levy SR, Testa FM, Smith-Rapaport S, Beckerman B. Early development of intractable epilepsy in children: a prospective study. Neurology 2001; 56: 1445–52.




    1. MacDonald BK, Johnson AL, Goodridge DM, Cockerell OC, Sander JW, Shorvon SD. Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol 2000; 48: 833-41.




    1. Stephen LJ, Kwan P, Brodie MJ. Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment? Epilepsia 2001; 42: 357-62.




    1. Siddiqui A, Kerb R, Weale ME, Brinkmann U, Smith A, Goldstein DB, et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 2003; 348: 1442-8.

    2. Arroyo S, Brodie MJ, Avanzini G, Baumgartner C, Chiron C, Dulac O, et al. Is refractory epilepsy preventable? Epilepsia 2002; 43: 437-44.

    3. Binnie CD, Polkey ChE. Commission on Neurosurgery of the International League Against Epilepsy (ILAE) 1993-1997: Recommended Standards. Epilepsia 2000; 41: 1346-9.

    4. Pre-surgical evaluation for epilepsy surgery - European standards. European Federation of Neurological Societies Task Force. Eur J Neurol 2000; 7: 119-22.

    5. Holmes G. Epilepsy surgery in children: when, why, and how. Neurology 2002; 58 (Suppl 7): S13-20.

    6. Rydenhag B, Silander HC. Complications of epilepsy surgery after 654 procedures in Sweden, September 1990-1995: a multicenter study based on the Swedish National Epilepsy Surgery Register. Neurosurgery 2001; 49:51-6.

    7. Sánchez-Álvarez JC, Altuzarra-Corral A. Cirugía de la epilepsia. Rev Neurol 2001; 33: 353-68.

    8. Rosenow F, Lüders H. Presurgical evaluation of epilepsy. Brain 2001; 124: 1683-700.

    9. Sánchez-Álvarez JC, Serrano-Castro PJ, Pastor-Pons E, Altuzarra-Corral A, García del Moral-Garrido R. Paciente de 45 años con epilepsia del lóbulo temporal desde la infancia. Rev Neurol 2002; 35: 481-97.

    10. Haut SR, Berg AT, Shinnar S, Cohen HW, Bazil CW, Sperling MR, et al. Interrater reliability among epilepsy centers: multicenter study of epilepsy surgery. Epilepsia 2002; 43: 1396-401.

    11. Sánchez-Alvarez JC, en representación del Grupo Andaluz Interdisciplinario contra la Epilepsia (GAICE). Unidades clínicas de epilepsia. Rev Neurol 2003; 37: 790-6.

    12. Spencer SS, Berg AT, Vickrey BG, Sperling MR, Bazil CW, Shinnar S, et al. Initial outcomes in the Multicenter Study of Epilepsy Surgery. Neurology 2003; 61: 1680-5.

    13. Yoon HH, Kwon HL, Mattson RH, Spencer DD, Spencer SS. Long-term seizure outcome in patients initially seizure-free after resective epilepsy surgery. Neurology 2003; 61: 445-50.

    14. Sirven JI, Malamut BL, O’Connor MJ, Sperling MR. Temporal lobectomy outcome in older versus younger adults. Neurology 2000; 54: 2166-70.

    15. Wiebe S, Blume WT, Girvin JP, Eliasziw M; effectiveness and efficiency of surgery for temporal lobe epilepsy study group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001; 345: 311-8.

    16. Engel J Jr, Wiebe S, French J, Sperling M, Williamson P, Spencer D, et al. Practice parameter: Temporal lobe and localized neocortical resections for epilepsy: Report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology 2003; 60: 538-47.

    17. Foldvary N, Bingaman WE, Wyllie E. Surgical treatment of epilepsy. Neurol Clin 2001; 19: 491-515.

    18. Cook SW, Nguyen ST, Hu B, Yudovin S, Shields WD, Vinters HV, et al. Cerebral hemispherectomy in pediatric patients with epilepsy: comparison of three tecniques by pathological substrate in 115 patients. J Neurosurg 2004; 100: 125-41.

    19. Spencer SS, Schramm J, Wyler A, O'Connor M, Orbach D, Krauss G, et al. Multiple subpial transection for intractable partial epilepsy: an international meta-analysis. Epilepsia 2002; 43: 141-5.

    20. Regis J, Bartolomei F, Hayashi M, Chauvel P. Gamma knife surgery, a neuromodulation therapy in epilepsy surgery. Acta Neurochir Suppl 2002; 84: 37-47.

    21. Fisher RS, Handforth A. Reassessment: Vagus nerve stimulation for epilepsy. A Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1999; 53: 666-9.

    22. Theodore WH, Fisher RS. Brain stimulation for epilepsy. Lancet Neurol 2004; 3: 111-8.



    Compartir con tus amigos:
  • 1   ...   5   6   7   8   9   10   11   12   13


    La base de datos está protegida por derechos de autor ©bazica.org 2019
    enviar mensaje

        Página principal